应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BBNX Beta Bionics, Inc.
休市中 08-21 16:00:00 EDT
19.05
-0.43
-2.21%
盘后
19.05
+0.00
0.00%
19:30 EDT
最高
19.54
最低
18.54
成交量
49.66万
今开
19.50
昨收
19.48
日振幅
5.13%
总市值
8.49亿
流通市值
4.63亿
总股本
4,456万
成交额
948.37万
换手率
2.04%
流通股本
2,429万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Beta Bionics推出Bionic Reports™中的Bionic Insights™功能——变革临床医生理解与优化糖尿病护理的方式
美股速递 · 03-31
Beta Bionics推出Bionic Reports™中的Bionic Insights™功能——变革临床医生理解与优化糖尿病护理的方式
Beta Bionics(BBNX.US)获Stifel首次覆盖,给予买入评级, 目标价25.00美元。
金融界 · 2025-02-24
Beta Bionics(BBNX.US)获Stifel首次覆盖,给予买入评级, 目标价25.00美元。
Beta Bionics(BBNX.US)获Lake Street首次覆盖,给予买入评级, 目标价30.00美元。
金融界 · 2025-02-24
Beta Bionics(BBNX.US)获Lake Street首次覆盖,给予买入评级, 目标价30.00美元。
Beta Bionics(BBNX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价26.00美元。
金融界 · 2025-02-24
Beta Bionics(BBNX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价26.00美元。
Beta Bionics(BBNX.US)获Leerink Partners首次覆盖,给予优于大市评级, 目标价28.00美元。
金融界 · 2025-02-24
Beta Bionics(BBNX.US)获Leerink Partners首次覆盖,给予优于大市评级, 目标价28.00美元。
加载更多
公司概况
公司名称:
Beta Bionics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Beta Bionics, Inc.于2015年10月21日作为马萨诸塞州福利公司注册成立,并于2024年8月转换为特拉华州公司。公司是一家商业化阶段的医疗器械公司,从事创新解决方案的设计、开发和商业化,通过利用先进的自适应闭环算法简化和改善其疾病的治疗,提高胰岛素需求糖尿病患者的健康和生活质量。
发行价格:
--
{"stockData":{"symbol":"BBNX","market":"US","secType":"STK","nameCN":"Beta Bionics, Inc.","latestPrice":19.05,"timestamp":1787342400000,"preClose":19.48,"halted":0,"volume":496596,"hourTrading":{"tag":"盘后","latestPrice":19.05,"preClose":19.05,"latestTime":"19:30 EDT","volume":1688,"amount":32159.06,"timestamp":1787355007631,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02207392197125255,"floatShares":24289699,"shares":44561695,"eps":-1.64865,"marketStatus":"休市中","change":-0.43,"latestTime":"08-21 16:00:00 EDT","open":19.5,"high":19.54,"low":18.54,"amount":9483675.566136,"amplitude":0.051335,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.64865,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1738213200000,"exchange":"NASDAQ","adjPreClose":19.48,"preHourTrading":{"tag":"盘前","latestPrice":19.11,"preClose":19.48,"latestTime":"09:25 EDT","volume":2248,"amount":44037.951327999996,"timestamp":1787318727175,"change":-0.37,"changeRate":-0.018994,"amplitude":0.145791},"postHourTrading":{"tag":"盘后","latestPrice":19.05,"preClose":19.05,"latestTime":"19:30 EDT","volume":1688,"amount":32159.06,"timestamp":1787355007631,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.30801640551206194,"impliedVol":0.2755,"impliedVolPercentile":0.0206},"requestUrl":"/m/hq/s/BBNX","defaultTab":"news","newsList":[{"id":"1113459701","title":"Beta Bionics推出Bionic Reports™中的Bionic Insights™功能——变革临床医生理解与优化糖尿病护理的方式","url":"https://stock-news.laohu8.com/highlight/detail?id=1113459701","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113459701?lang=zh_cn&edition=full","pubTime":"2026-03-31 18:02","pubTimestamp":1774951345,"startTime":"0","endTime":"0","summary":"Beta Bionics, Inc. (BBNX) 近日宣布,在其Bionic Reports™平台中全新引入了Bionic Insights™功能。这一创新工具旨在彻底改变临床医生理解和优化糖尿病护理的方式,通过提供更深入、更智能的数据分析,帮助医疗专业人员制定更精准的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513777845","title":"Beta Bionics(BBNX.US)获Stifel首次覆盖,给予买入评级, 目标价25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513777845","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513777845?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:21","pubTimestamp":1740410466,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Stifel首次覆盖,给予买入评级, 目标价25.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24232148353170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513722329","title":"Beta Bionics(BBNX.US)获Lake Street首次覆盖,给予买入评级, 目标价30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722329","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513722329?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:22","pubTimestamp":1740406925,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Lake Street首次覆盖,给予买入评级, 目标价30.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24222248352806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513272995","title":"Beta Bionics(BBNX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价26.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513272995","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513272995?lang=zh_cn&edition=full","pubTime":"2025-02-24 21:21","pubTimestamp":1740403316,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价26.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24212148352460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513723151","title":"Beta Bionics(BBNX.US)获Leerink Partners首次覆盖,给予优于大市评级, 目标价28.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513723151","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513723151?lang=zh_cn&edition=full","pubTime":"2025-02-24 20:20","pubTimestamp":1740399654,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Leerink Partners首次覆盖,给予优于大市评级, 目标价28.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24202048351403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.betabionics.com","stockEarnings":[{"period":"1week","weight":0.0842},{"period":"1month","weight":0.168},{"period":"3month","weight":0.6117},{"period":"6month","weight":0.3905},{"period":"1year","weight":0.1279},{"period":"ytd","weight":-0.3748}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Beta Bionics, Inc.于2015年10月21日作为马萨诸塞州福利公司注册成立,并于2024年8月转换为特拉华州公司。公司是一家商业化阶段的医疗器械公司,从事创新解决方案的设计、开发和商业化,通过利用先进的自适应闭环算法简化和改善其疾病的治疗,提高胰岛素需求糖尿病患者的健康和生活质量。","exchange":"NASDAQ","name":"Beta Bionics, Inc.","nameEN":"Beta Bionics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beta Bionics, Inc.(BBNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Beta Bionics, Inc.(BBNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Beta Bionics, Inc.,BBNX,Beta Bionics, Inc.股票,Beta Bionics, Inc.股票老虎,Beta Bionics, Inc.股票老虎国际,Beta Bionics, Inc.行情,Beta Bionics, Inc.股票行情,Beta Bionics, Inc.股价,Beta Bionics, Inc.股市,Beta Bionics, Inc.股票价格,Beta Bionics, Inc.股票交易,Beta Bionics, Inc.股票购买,Beta Bionics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beta Bionics, Inc.(BBNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Beta Bionics, Inc.(BBNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}